CDX2 and colorectal carcinoma: A literature review identified 18 studies reporting on loss of CDX2 expression in relation to clinicopathological characteristics and prognosis in CRC (Table S4), of which eleven reported that loss of CDX2 expression was associated with a poor prognosis and three studies reported no difference, while none found that loss of CDX2 was associated with a good prognosis.